Icagen, Inc.

Icagen, Inc.

Icagen, Inc.

Icagen offers industry-leading scientific expertise and comprehensive services for ion channel and transporter drug discovery and development.
Founded
1992
Raised
$3.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$2,000,000
Post-IPO equity - 2017
$1,150,000
Post-IPO debt - 2016
Team Size
1–10
Employees
Xconomy

Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential

$2,000,000 Post-IPO equity
wraltechwire

Icagen raises another $2M in latest fundraiser -TechWire Insider :: Editor's Blog at WRAL TechWire

Xconomy

Icagen Boosts Drug Discovery Capabilities With Sanofi Site Purchase

Health Strategy